Obiageli Ezekwesili
Primary Care · Helotes, TXNPI 1699174102
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,967 of the $4,469 with a category attached, or 66.4%. 23 manufacturers reported payments, led by Brainsway USA Inc at 33.6% of the total. 2025 is the largest year on record at $1,809, 6.6 times the $274 reported in 2021. Among primary care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $154.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainsway USA Inc$2K
- Si-bone, Inc.$459
- Abbott$329
- Biohaven Pharmaceutical Holding Company Ltd.$245
- Boston Scientific$143
- Silk Road Medical, Inc.$143
- plus $2K from 17 others
What the payments were for
- Travel & lodging$1,50234%
- Food & beverage$2,96766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainsway USA Inc | 1 | $1,502 |
| Si-bone, Inc. | 4 | $459 |
| Abbott | 3 | $329 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $245 |
| Boston Scientific | 1 | $143 |
| Silk Road Medical, Inc. | 1 | $143 |
| Johnson & Johnson | 1 | $138 |
| AbbVie | 1 | $125 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $124 |
| Bayer | 1 | $122 |
| Abiomed | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $114 |
| Edwards Lifesciences | 1 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $106 |
| Lucid Diagnostics Inc. | 1 | $102 |
| Stemline Therapeutics Inc. | 1 | $98 |
| W. L. Gore & Associates, Inc. | 1 | $92 |
| Genentech USA, Inc. | 1 | $71 |
| Coloplast | 1 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Merck | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- deep tms$1,502
- ENROUTE Transcarotid Neuroprotection System$286
- NURTEC ODT$245
- AMS 700$143
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$143
- ENROUTE Transcarotid Stent$143
- SPRAVATO$138
- GEMTESA$125
- VRAYLAR$125
- Kerendia$122
- Impella$119
- Austedo XR$114
- GATTEX$114
- FREESTYLE LIBRE 3$111
- Edwards SAPIEN 3 Transcatheter Heart Valve$109
- ENSITE PRECISION$109
- FreeStyle Libre 2$108
- TRULANCE$106
How this compares
$4,469 in reported general payments places this provider in the 90th percentile of 563 primary care providers in Texas.
Other primary care in Helotes
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
- Jacqueline MilesGrand Prairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.